I hope you understand our frustration and, Dr. Schohn, I am going to ask you to provide for the Committee a detailed audit of how the $5.7 billion has been spent.

I remember last time, and I cannot remember whether it happened, Chairman, in the last hearing but we had one that dealt with suicides.

I hope you will put into your equation your answer to a lot of issues today. We have an implementation problem.

VA focuses on medication management.

We urge the Committee to demand more.

I think these are all things that we will follow up in detail.

I think you've got to weigh in this equation. How much are we increasing the cost of devices?

Do you acknowledge that an increase in the user fee is eventually passed on to the consumer?

I commend the FDA on their decision on the 510(k) because I think that it does embrace what it set out to.

I rise today to highlight the introduction of important bipartisan legislation to reauthorize the Pandemic and All-Hazards Preparedness Act of 2006 and the BioShield Special Reserve Fund. I am pleased to be joined by my colleagues…

I say to my colleagues that there were a lot of blanket statements about one's level of participation. I have negotiated with the chairman of this committee for 9 months on the reauthorization of our emergency preparedness and biodefense…

If the Senator interpreted my comments to be personally targeted to him, then I do apologize. The Senator said--and I wrote it down: I spent more time on this bill than any other bill ever. My criticism about the statement was, I said: If…